References
- Ball, J.C., & Corty, E. (1988). Basic issues pertaining to the effectiveness of methadone maintenance system NIDA research monograph 86:178–91
- Ball, J.C., Lange, W.R., Meyers, C.P., & Friedman, S.R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. The Journal of Health and Social Behavior, 29, 214–226
- Ball, J.C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York: Spring-Verlag
- Bourdieu, P. (1990). The logic of practice. California: Polity Press
- Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24, 165–195
- Bourgois, P., & Schonberg, J. (2009). Righteous dopefiend. California: University of California Press
- Deck, D., Carlson, M.J. (2005). Retention in publicly funded methadone maintenance treatment in two western states. The Journal of Behavioral Health Services and Research, 21, 43–60
- Dole, V., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride. Journal of American Medical Association, 193, 646–650
- Foucault, M. (1990). The history of sexuality. Volume 1: An introduction. New York: Vintage Books
- Gartry, C.C., Oviedo-Joekes, E., Laliberté, N., & Schechter, M.T. (2009). NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America. Harm Reduction Journal, 6, 2
- Glaser, BG., Strauss, AL. (1967). The discovery of grounded theory: Strategies for qualitative research. New Brunswick, NJ and London, UK: Aldine Transaction
- Heller, D.I., & Stancliff, S. (2003). Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City. Public Health Reports, 122, 393–397
- Hubbard, R.L., Marsden, M.E., Rachal, J.V., Harwood, H.J., Cavanaugh, E.R., Ginzburg, H.M. (1989). Drug abuse treatment a national study of effectiveness. Chapel Hill: The University of North Carolina Press
- Joseph, H., & Stancliff, S. (2000). Methadone maintenance treatment: A review of historical and clinical issues. The Mount Sinai Journal of Medicine, 67, 347–364
- Keane, H. (2009). Foucault on methadone: Beyond biopower. International Journal of Drug Policy, 20, 450–452
- Kreek, M.J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of addiction: Methadone. Journal of Addiction Disorders, 29, 200–216
- Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. The Mount Sinai Journal of Medicine, 68, 62–74
- Magura, S., Lee, J.D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug and Alcohol Dependence, 99, 222–230
- Magura, S., Rosenblum, A., Fong, C., Villano, C., & Richman, B. (2002). Treating cocaine-using methadone patients: Predictors of outcomes in a psychosocial clinical trial. Substance Use and Misuse, 37, 1927–1955
- Magura, S., Nwakeze, P.C., & Demsky, S. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51–60
- National Institutes on Drug Abuse (NIDA). (2010). Drugs, brains and behavior: The science of addiction. National Institutes on Drug Abuse. Retrieved from http://www.drugabuse.gov/publications/science-addiction
- Office of Alcohol and Substance Abuse Services, Part 822, Subpart 822-5. Retrieved on April 23 2014 from http://www.oasas.ny.gov/mis/forms/reg/822/part822.cfm
- Patton, M.Q. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks, London, New Delhi: Sage
- Peterson, J.A., Schwartz, R.P., Mitchell, S.G., Reisinger, H.S., Kelly, S.M., O’Grady, K.E. … Agar, M.H. (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy, 21, 36–42
- Pollack, H., & D’Aunno, T. (2008). Dosage patterns in methadone treatment: Results from a National survey 1988-2005. Health Services Research, 43, 2143–2163
- Reisinger, H.S., Schwartz, R.P., Mitchell, S.G., Peterson, J.A., Kelly, S.M., O’Grady, K.E. … Agar, M.H. (2009). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs, 41, 285–296
- Rosenblum, A., Parrino, M., Schnoll, S.H., Fong, C., Maxwell, C., Cleland, C.M. … Haddox, D.J. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90, 64–71
- Schwartz, R.P., Kelly, S.M., O’Grady, K.E., Peterson, J.A., Reisinger, H.S., Mitchell, S.G. … Brown BS. (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse, 34, 17–28
- Simpson, D.D., & Sells, S.B. (1982) Effectiveness of Treatment for Drug Use: An Overview of the DARP Research Program. Advances in Alcohol and Substance Abuse, 2, 7–29
- Simpson, D.D., & Sells, S.B. (1983). Effectiveness of treatment for drug abuse: An overview of the DARP Research Program. Hawthorn Press
- Stancliff, S., Myers, J.E., Steiner, S., & Drucker, E. (2002). Beliefs about methadone in an inner-city methadone clinic. Journal of Urban Health, 79, 571–578
- Stotts, A., Dodrill, C.L., & Kosten, T.R. (2010). Opioid dependence treatment: Options in pharmacology. Expert Opinions in Pharmacotherapy, 10, 1727–1740
- Strain, E.C., Bigelow, G.E., Liebson, I.A., & Stitzer, M.L. (1999). Moderate- vs high- dose methadone in the treatment of opioid dependence: A randomized trial. JAMA, 281, 1000–1005
- van den Brink, W., Hendriks, V.M., Blanken, P., Koeter, M.W., van Zwieten, B.J., & van Ree, J.M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal, 327, 310–315
- Zinberg, N. (1984). Drug, set, setting: The basis for controlled intoxicant use. New Haven: Yale University Press